Surface-Charged Poly(Lactide-Co-Glycolide) Microparticles as Novel Antigen Delivery Systems

Vaccine Adjuvants and Delivery Systems

Volumn , Issue , 2006, Pages 223-247

  Singh, Manmohan ^a   Chesko, James ^a   Kazzaz, Jina ^a   Ugozolli, Mildred ^a   Malyala, Padma ^a   O'Hagan, Derek T ^a  

^a MS X 600A   (United States)

Author keywords

Charged microparticles for induction; Mucosal immunization with microparticles; Surface charged poly(lactide co glycolide) microparticles

Indexed keywords

EID: 78650467778     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470134931.ch10     Document Type: Chapter

References (82)

1. O'Hagan, D.T. Microparticles as oral vaccines. In Novel Delivery Systems for Oral Vaccines, O'Hagan, D.T., Ed., CRC Press, Boca Raton, FL, 1994, pp. 175-205.
2. Okada, H. & Toguchi, H. Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst 1995, 12(1), 1-99.
3. Putney, S.D. & Burke, P.A. Improving protein therapeutics with sustained-release formulations. Nat Biotechnol 1998, 16(2), 153-157 [published erratum appears in Nat Biotechnol 1998 May, 16(5), 478].
4. Eldridge, J.H., Staas, J.K., Meulbroek, J.A., Tice, T.R. & Gilley, R.M. Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect Immun 1991, 59(9), 2978-2986.
5. O'Hagan, D.T., Rahman, D., McGee, J.P. et al. Biodegradable microparticles as controlled release antigen delivery systems. Immunology 1991, 73(2), 239-242.
6. Singh, M., Singh, A. & Talwar, G.P. Controlled delivery of diphtheria toxoid using biodegradable poly(d,l-lactide) microcapsules. Pharm Res 1991, 8(7), 958-961.
7. O'Hagan, D.T., Jeffery, H., Roberts, M.J., McGee, J.P. & Davis, S.S. Controlled release microparticles for vaccine development. Vaccine 1991, 9(10), 768-771.
8. Maloy, K.J., Donachie, A.M., O'Hagan, D.T. & Mowat, A.M. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology 1994, 81(4), 661-667.
9. Moore, A., McGuirk, P., Adams, S. et al. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells. Vaccine 1995, 13(18), 1741-1749.
10. Nixon, D.F., Hioe, C., Chen, P.D. et al. Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine 1996, 14(16), 1523-1530.
11. Kanke, M., Sniecinski, I. & DeLuca, P.P. Interaction of microspheres with blood constituents: I. Uptake of polystyrene spheres by monocytes and granulocytes and effect on immune responsiveness of lymphocytes. J Parenter Sci Technol 1983, 37(6), 210-217.
12. Tabata, Y. & Ikada, Y. Macrophage phagocytosis of biodegradable microspheres composed of l-lactic acid/glycolic acid homo-and copolymers. J Biomed Mater Res 1988, 22(10), 837-858.
13. Tabata, Y. & Ikada, Y. Phagocytosis of polymer microspheres by macrophages. Adv Polym Sci 1990, 94, 107-141.
14. Randolph, G.J., Inaba, K., Robbiani, D.F., Steinman, R.M. & Muller, W.A. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999, 11(6), 753-761.
15. Lutsiak, M.E., Robinson, D.R., Coester, C., Kwon, G.S. & Samuel, J. Analysis of poly(d,l-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro. Pharm Res 2002, 19(10), 1480-1487.
16. Newman, K.D., Elamanchili, P., Kwon, G.S. & Samuel, J. Uptake of poly(d,l-lacticco-glycolic acid) microspheres by antigen-presenting cells in vivo. J Biomed Mater Res 2002, 60(3), 480-486.
17. O'Hagan, D.T., Jeffery, H. & Davis, S.S. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine 1993, 11(9), 965-969.
18. O'Hagan, D.T., Ugozzoli, M., Barackman, J. et al. Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1. Vaccine 2000, 18(17), 1793-1801.
19. Kazzaz, J., Neidleman, J., Singh, M., Ott, G. & O'Hagan, D.T. Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. J Control Release 2000, 67(2-3), 347-356.
20. Singh, M., Chesko, J., Kazzaz, J. et al. Adsorption of a novel recombinant glycoprotein from HIV (Env gp120dV2SF162) to anionic PLG microparticles retains the structural integrity of the protein, while encapsulation in PLG microparticles does not. Pharm Res 2004, 21(12), 2148-2152.
21. Singh, M., Kazzaz, J., Chesko, J. et al. Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B. J Pharm Sci 2004, 93(2), 273-282.
22. Singh, M., Ugozzoli, M., Kazzaz, J. et al. A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens. Vaccine 2006, 24(10), 1680-1686.
23. Jung, T., Kamm, W., Breitenbach, A., Hungerer, K.D., Hundt, E. & Kissel, T. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly (lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharm Res 2001, 18(3), 352-360.
24. O'Hagan, D.T., Jeffery, H. & Davis, S.S. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine 1993, 11(9), 965-969.
25. Otten, G.R., Doe, B., Schaefer, M. et al. Relative potency of cellular and humoral immune responses induced by dna vaccination. Intervirology 2000, 43(4-6), 227-232.
26. Parker, S.E., Borellini, F., Wenk, M.L. et al. Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits. Hum Gene Ther 1999, 10(5), 741-758.
27. Parker, S.E., Monteith, D., Horton, H. et al. Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine. Gene Ther 2001, 8(13), 1011-1023.
28. Ulmer, J.B., Donnelly, J.J., Parker, S.E. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259(5102), 1745-1749.
29. Donnelly, J.J., Ulmer, J.B., Shiver, J.W. & Liu, M.A. DNA vaccines. Annu Rev Immunol 1997, 15, 617-648.
30. Gurunathan, S., Klinman, D.M. & Seder, R.A. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000, 18, 927-974.
31. Wang, R., Doolan, D.L., Le, T.P. et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 1998, 282(5388), 476-480.
32. Roy, M.J., Wu, M.S., Barr, L.J. et al. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 2000, 19(7-8), 764-778.
33. Seder, R.A. & Gurunathan, S. DNA vaccines: designer vaccines for the 21st century. N Engl J Med 1999, 341(4), 277-278.
34. Calarota, S., Bratt, G., Nordlund, S. et al. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 1998, 351(9112), 1320-1325.
35. Schneider, J., Gilbert, S.C., Blanchard, T.J. et al. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 1998, 4(4), 397-402.
36. Sullivan, N.J., Sanchez, A., Rollin, P.E., Yang, Z.Y. & Nabel, G.J. Development of a preventive vaccine for Ebola virus infection in primates. Nature 2000, 408(6812), 605-609.
37. Amara, R.R., Villinger, F., Altman, J.D. et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001, 292(5514), 69-74.
38. Hedley, M.L., Curley, J. & Urban, R. Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nat Med 1998, 4(3), 365-368.
39. Walter, E., Moelling, K., Pavlovic, J. & Merkle, H.P. Microencapsulation of DNA using poly(dl-lactide-co-glycolide): stability issues and release characteristics. J Control Release 1999, 61, 361-374.
40. Ando, S., Putnam, D., Pack, D.W. & Langer, R. PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J Pharm Sci 1999, 88(1), 126-130.
41. Tinsley-Bown, A.M., Fretwell, R., Dowsett, A.B., Davis, S.L. & Farrar, G.H. Formulation of poly(d,l-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J Control Release 2000, 66(2-3), 229-241.
42. Singh, M., Briones, M., Ott, G. & O'Hagan, D. Cationic microparticles: a potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 2000, 97(2), 811-816.
43. Singh, M., Ugozzoli, M., Briones, M., Kazzaz, J., Soenawan, E. & O'Hagan, D. The effect of CTAB concentration in cationic PLG microparticles on DNA adsorption and in vivo performance. Pharm Res 2003, 20(2), 244-248.
44. Briones, M., Singh, M., Ugozzoli, M. et al. The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery. Pharm Res 2001, 18(5), 709-711.
45. O'Hagan, D., Singh, M., Ugozzoli, M. et al. Induction of potent immune responses by cationic microparticles with adsorbed HIV DNA vaccines. J Virol 2001, 75(19), 9037-9043.
46. Denis-Mize, K.S., Dupuis, M., MacKichan, M.L. et al. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther 2000, 7(24), 2105-2112.
47. Ott, G., Singh, M., Kazzaz, J. et al. A cationic sub-micron emulsion (MF59/DOTAP) is an effective delivery system for DNA vaccines. J Control Release 2002, 79(1-3), 1-5.
48. Singh, M., Ott, G., Kazzaz, J. et al. Cationic microparticles are an effective delivery system for immune stimulatory CpG DNA. Pharm Res 2001, 18(10), 1476-1479.
49. Xie, H., Gursel, I., Ivins, B.E. et al. CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine. Infect Immun 2005, 73(2), 828-833.
50. Tabata, Y. & Ikada, Y. Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres. J Pharm Pharmacol 1987, 39(9), 698-704.
51. Puri, N. & Sinko, P.J. Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres: II. In vivo investigation. J Control Release 2000, 69(1), 69-80.
52. Cleland, J.L., Barron, L., Daugherty, A. et al. Development of a single-shot subunit vaccine for HIV-1: 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120. J Pharm Sci 1997, 85(12), 1350-1357.
53. O'Hagan, D.T. HIV and mucosal immunity. Lancet 1991, 337(8752), 1289.
54. O'Hagan, D.T., Singh, M., Kazzaz, J. et al. Synergistic adjuvant activity of immunostimulatory DNA and oil/water emulsions for immunization with HIV p55 Gag antigen. Vaccine 2002, 20(27-28), 3389-3398.
55. Singh, M., Ott, G., Kazzaz, J. et al. Cationic microparticles are an effective delivery system for immune stimulatory CpG DNA. Pharm Res 2001, 18(10), 1476-1479.
56. O'Hagan, D.T. Intestinal translocation of particulates: implications for drug and antigen delivery. Adv Drug Deliv Rev 1990, 5, 265-285.
57. O'Hagan, D.T. The intestinal uptake of particles and the implications for drug and antigen delivery. J Anat 1996, 189(Pt 3), 477-482.
58. Jepson, M.A., Simmons, N.L., O'Hagan, D.T. & Hirst, B.H. Comparison of poly(dllactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells. J Drug Target 1993, 1(3), 245-249.
59. O'Hagan, D.T., Palin, K., Davis, S.S., Artursson, P. & Sjoholm, I. Microparticles as potentially orally active immunological adjuvants. Vaccine 1989, 7(5), 421-424.
60. O'Hagan, D.T., Palin, K.J. & Davis, S.S. Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunization. Vaccine 1989, 7(3), 213-216.
61. Eldridge, J.H., Meulbroek, J.A., Staas, J.K., Tice, T.R. & Gilley, R.M. Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Adv Exp Med Biol 1989, 251, 191-202.
62. Challacombe, S.J., Rahman, D., Jeffery, H., Davis, S.S. & O'Hagan, D.T. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology 1992, 76(1), 164-168.
63. Eldridge, J.H., Hammond, C.J., Meulbroek, J.A., Staas, J.K., Gilley, R.M. & Tice, T.R. Controlled vaccine release in the gut-associated lymphoid tissues: I. Orally administered biodegradable microspheres target the Peyer's patches. J Control Release 1990, 11, 205-214.
64. O'Hagan, D. Microparticles and polymers for the mucosal delivery of vaccines. Adv Drug Deliv Rev 1998, 34(2-3), 305-320.
65. Jones, D.H., McBride, B.W., Thornton, C., O'Hagan, D.T., Robinson, A. & Farrar, G.H. Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection. Infect Immun 1996, 64(2), 489-494.
66. Jones, D.H., Corris, S., McDonald, S., Clegg, J.C. & Farrar, G.H. Poly(dl-lactideco-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 1997, 15(8), 814-817.
67. Chen, S.C., Jones, D.H., Fynan, E.F. et al. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol 1998, 72(7), 5757-5761.
68. Kaneko, H., Bednarek, I., Wierzbicki, A. et al. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein. Virology 2000, 267(1), 8-16.
69. Mathiowitz, E., Jacob, J.S., Jong, Y.S. et al. Biologically erodable microspheres as potential oral drug delivery systems. Nature 1997, 386(6623), 410-414.
70. Roy, K., Mao, H.Q., Huang, S.K. & Leong, K.W. Oral gene delivery with chitosan: DNA nanoparticles generates immunologic protection in a murine model of peanut allergy [see comments]. Nat Med 1999, 5(4), 387-391.
71. O'Hagan, D. T. & Singh, M. Microparticles as vaccine adjuvants and delivery systems. Expert Rev Vaccines 2003, 2(2), 269-283.
72. Singh, M., Vajdy, M., Gardner, J., Briones, M. & O'Hagan, D.T. Mucosal immunization with HIV-1 Gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity. Vaccine 2001, 20(3-4), 594-602.
73. Levine, M.M. & Dougan, G. Optimism over vaccines administered via mucosal surfaces. Lancet 1998, 351, 1375-1376.
74. Vajdy, M. & O'Hagan, D.T. Microparticles for intranasal immunization. Adv Drug Deliv Rev 2001, 51(1-3), 127-141.
75. Denis-Mize, K., Dupuis, M., Singh, M. et al. Mechanisms of increased immunogenicity for DNA-based vaccines absorbed onto cationic microparticles. Cell Immunol 2003, 225(1), 12-20.
76. Denis-Mize, K.S., Dupuis, M., MacKichan, M.L. et al. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther 2000, 7(24), 2105-2112.
77. Klencke, B., Matijevic, M., Urban, R.G. et al. Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a phase I study of ZYC101. Clin Cancer Res 2002, 8(5), 1028-1037.
78. Sheets, E.E., Urban, R.G., Crum, C.P. et al. Immunotherapy of human cervical high-grade cervical intraepithelial neoplasia with microparticle-delivered human papillomavirus 16 E7 plasmid DNA. Am J Obstet Gynecol 2003, 188(4), 916-926.
79. Park, T.G., Lu, W. & Crotts, G. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactic acid-co-glycolic acid) microspheres. J Control Release 1995, 33, 211-219.
80. Shenderova, A., Burke, T.G. & Schwendeman, S.P. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins. Pharm Res 1999, 16(2), 241-248.
81. van de Weert, M., Hennink, W.E. & Jiskoot, W. Protein instability in poly(lactic-coglycolic acid) microparticles. Pharm Res 2000, 17(10), 1159-1167.
82. Johnson, R.E., Lanaski, L.A., Gupta, V. et al. Stability of atriopeptin III in poly(lactide-co-glycolide) microparticles. J Control Release 1991, 17, 61.